
Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
Author(s) -
Yanwei Luo,
Xiaopeng Huang,
Jun Zhan,
Shuai Zhang
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s337769
Subject(s) - nomogram , hepatocellular carcinoma , medicine , oncology , cohort , stage (stratigraphy) , biomarker , cirrhosis , cancer research , biology , paleontology , biochemistry
Due to the limitations of currently available biomarkers, new biomarkers are needed to accurately predict the prognosis of patients with hepatocellular carcinoma (HCC) patients.